Objective: To investigate the incidence and trends in colorectal cancer (CRC) among Asian American populations in the United States.
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patients and 16,414 corresponded to female patients (47.1%).
The median age was 68 years, and 97.7% cases were confirmed by positive histologic findings. The overall annual ageadjusted incidence of CRC for Asian Americans in the United States was 41.0 per 100,000 per year (Table 1) , which is much lower than that for non-Hispanic whites (45.1 per 100,000), blacks (55.2 per 100,000), and other races (59.9 per 100,000).
The age-specific rate was the lowest among those younger than 50 years (6.0 per 100,000 per year), but it increased to 119.7 per 100,000 (20-fold) among those aged 60-69 years, and 276.4 per 100,000 (46-fold) for those aged 80 years or older. The incidence rate declined from 46.0 per 100,000 for 1994-1998 to 35.7 per 100,000 for 2009-2013. There were substantial geographic variations in incidence rates across different geographic areas. The incidence rates were lowest in New Mexico (20.0 per 100,000), and the highest in Hawaii (49.3 per 100,), with corresponding relative risks between 1.96 and 3.16. The CRC incidence rates among various registries can be roughly divided into three levels: low (<30 per 100,000
for New Mexico, Iowa, Detroit, Atlanta, and Connecticut), medium (30-40 per 100,000 for Utah, San Jose, and Seattle), and high (>40 per 100,000 for Los Angeles and Hawaii). Most CRCs were in localized or regional stages, and they accounted for about 40% and 35% of the total respectively. The proportions of in situ and distant stages were relatively small: 3% and 16% respectively. Further subdivision of the time periods included in the analysis (1994-1998, 1999-2003, 2004-2008, and 2009-2013) did not result in any appreciable differences in cancer incidence by sex or anatomic subsite.
The incidence rates between anatomic subsites were compared against sex, race, age group, years of diagnosis, registries, and stage (Table 2 ). For males, the proximal subsite had lowest incidence rate, but for women the rectum had the lowest incidence rate. For Asian Americans the incidence rates at different anatomic sites were almost the same, but for blacks the incidence for the proximal site was twice as great as that for the distal site or for the rectal sites (27 per 100,000 vs. 13.6 per 100,000 and 13.5 per 100,000 respectively) (data not shown).
Among Asian Americans the incidence rate of proximal-site CRC was higher than that at other sites but the difference was less than two-fold. Among the younger group aged less than 50 years, the incidence rate for the rectal site was the highest, the difference from the rate for the proximal site being more than two-fold (2.7 per 100,000 vs. 1.3 per 100,000). In contrast, among those aged 80 years or older, the incidence for the proximal site was almost twice that for the rectal site (125.4 per 100,000 vs. 70.2 per 100,000). The incidence differences between anatomic sites were smaller between different years and different geographic locations. The highest incidence at the in situ stage occurred for the distal site, and was four times higher than that for proximal site (2.0 per 100,000 vs. 0.6 per 100,000). The incidence rate for the rectal site at the same stage was 3.3 times greater than that for the proximal site.
Asian Americans in the United States experienced a statistically significant (1.8%, 95% CI −2.2% to 1.4%) annual decrease in CRC incidence from 1994 to 2013 ( CI 0.1-1.2%, and APC 0.3%, 95% CI −0.3% to 0.9%, respectively). Significant incidence decreases were observed for age groups older than 60 years. The APCs for those aged 60-69 years, 70-79 years, and 80 years or older were −1.8% (95% CI −2.2% to 1.4%), −2.6% (95% CI −1.9% to 3.4% ), and −3.3% (95% CI −2.6% to 3.9%) respectively. The incidence rate decreased for both sexes, with an APC of −1.7% for women and −1.9% for men (Fig. 3) . A significant decrease of CRC incidence was not observed in New Mexico, Iowa, Detroit, Utah, and Atlanta, but significant decrease of CRC incidence occurred in Connecticut, San Jose, Seattle, San Francisco, and Los Angeles. Connecticut had the biggest CRC incidence decrease (2.9%). The age-adjusted incidence trends at all the different stages had significant decreases ranging from −0.9% (localized) to −4.5% (in situ) annually (Fig. 4) . Among the anatomic sites, the distal anatomic site had the biggest decrease, with an APC of −2.5% (Fig. 5) . The APCs for the proximal and rectal sites were −1.3% and −1.8% respectively. Figure 6 ORIGINAL RESEARCH 
Discussion
The Asian American group is the fastest-growing minority group in the United States [15, 16] . According to the 2010 US Census, Asian Americans constitute about 4.8% of the US total population. The overall incidence of CRC in the United States has steadily decreased, but the incidence rates and trends have not been addressed for Asian American populations.
The CRC incidence rates for Asian Americans were lower than those for non-Hispanic whites, but the incidence difference between both groups has been becoming smaller since 2008 (incidence rate ratio 1.1 vs. 1.08 P<0.05). The incidence trends analysis shows that the decline in CRC incidence has been slower in Asian Americans than in non-Hispanic whites.
Although CRC screening has been shown to effectively decrease mortality, it remains the least used screening tool in the United States, and is particularly underused by Asian Age-adjusted incidence rate (1/100,000)
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Age-adjusted incidence rate (1/100,000) Americans [17] . Previous studies found lower CRC screening use among Asian Americans compared with non-Hispanic whites, where 46-51% of Asian Americans were up-to-date with CRC screening compared with 56-59% of their non-Hispanic white counterparts [18] [19] [20] [21] .
CRC is now the third most common malignant disease in both men and women in Asia, and the incidence and mortality have been rising rapidly in Asia [22] [23] [24] [25] [26] [27] . This has been attributed to dietary habits including an increase in the consumption of meat, animal fat, and preserved food, as well as lifestyle factors such as cigarette smoking, alcohol drinking, and physical inactivity [22] . The opposite direction of incidence change for Asian Americans in the United States might be related to the access to CRC screening. In the United States, overall 59.6%
reported being up-to-date on CRC screening in 2010. In East Asia and Southeast Asia, the participation rate in CRC screening programs is low, and colonoscopy has not been adopted as a primary population-based screening tool because of staffing constraints in relation to large population size, increased costs, and potential adverse events [28] .
The first guidelines for CRC screening were issued in 1989
by the US Preventive Services Task Force [29] , but the decrease in the incidence of CRC for the Asian American population in our study occurred in 2003, 5 years later than in the nonHispanic white population. According to the Behavioral Risk Factor Surveillance System data from 2010, the self-reported CRC screening rate was highest in white (62.0%), followed by blacks (59.0%), Hispanics (52.5%), and Asians (47.2%) [30] .
Therefore the lower CRC incidence decrease might be related to lower awareness of screening tests among immigrants [31] and the lower CRC screening participation rate in the Asian American group.
Even though incidence declines occurred in all the geographic areas, there was a significant incidence decrease only Angeles. There were only no significant decreases in New Mexico, Iowa, Detroit, Utah and Atlanta. This may also be related to the CRC screening rates in these areas; further study is needed.
Our analysis supports the inference of a relationship between the anatomic site and patients' age: more cancers were in the rectal site at younger ages (<50 years) and in proximal site at later ages. This pattern is similar to that in the study of Meyer et al. [32] but the reasons remain unknown. We also found that younger age increases the risk of lymph node positivity in early-stage rectal cancer [33] .
Our results show that the largest decrease in incidence overall occurred for the in situ stage. This may be related to the new CRC screening guideline (implemented in 1998) that promoted a higher CRC screening rate to detect precancerous polyps so they could be removed before progressing to CRC.
Kubisch et al. [34] found that screening for CRC using fecal occult blood tests and colonoscopy is associated with reduced CRC incidence and mortality [34] .
There are several limitations in interpreting these results.
First, each SEER registry is responsible for finding cancer cases in its defining registry area. Misdiagnosis and underregistration in SEER registries are potential issues [35] . Second, the data were from only 13 of 18 available registries, representing 14% of the US population, so they may not be representative of the general US population. Last, changes in diagnostic capabilities, including screening and pathology, may also influence the accuracy of incidence data collected over time [6] .
In spite of these potential limitations, our populationbased study provides trends in the incidence of CRC for Asian Americans in the United States and describes patterns that have not been reported previously. The diverse incidence patterns by age group, sex, stage, and anatomic site, along with geographic area, may be indicative of a specific cause. These data may be useful in planning public health strategies, identifying risks, and understanding the causes of CRC for future prevention.
